NorthCrest Asset Manangement’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.6M | Buy |
5,432
+97
| +2% | +$28.6K | 0.04% | 240 |
|
|
2025
Q1 | $1.64M | Sell |
5,335
-263
| -5% | -$81.1K | 0.05% | 230 |
|
|
2024
Q4 | $1.98M | Buy |
5,598
+84
| +2% | +$29.6K | 0.06% | 205 |
|
|
2024
Q3 | $1.98M | Buy |
5,514
+238
| +5% | +$85.3K | 0.06% | 207 |
|
|
2024
Q2 | $1.68M | Buy |
5,276
+1
| +0% | +$319 | 0.06% | 214 |
|
|
2024
Q1 | $1.21M | Sell |
5,275
-60
| -1% | -$13.8K | 0.04% | 254 |
|
|
2023
Q4 | $1.17M | Hold |
5,335
| – | – | 0.04% | 245 |
|
|
2023
Q3 | $1.21M | Hold |
5,335
| – | – | 0.05% | 235 |
|
|
2023
Q2 | $1.18M | Hold |
5,335
| – | – | 0.05% | 243 |
|
|
2023
Q1 | $1.19M | Hold |
5,335
| – | – | 0.05% | 235 |
|
|
2022
Q4 | $1.48M | Hold |
5,335
| – | – | 0.08% | 142 |
|
|
2022
Q3 | $1.12M | Hold |
5,335
| – | – | 0.06% | 195 |
|
|
2022
Q2 | $1.26M | Hold |
5,335
| – | – | 0.06% | 185 |
|
|
2022
Q1 | $957K | Buy |
5,335
+80
| +2% | +$14.4K | 0.05% | 206 |
|
|
2021
Q4 | $1.14M | Buy |
+5,255
| New | +$1.14M | 0.06% | 205 |
|